Fluorodeoxyglucose-positron emission tomography/computed tomography-based chemotherapy dosage adjustment in seminoma: The GETUG SEMITEP trial

被引：0
|
作者：
Dheeroo, Dheeraj Kumar [1 ]
机构：
[1] All India Inst Med Sci, Dept Urol, Bhubaneswar, Odisha, India
来源：
INDIAN JOURNAL OF UROLOGY | 2022年 / 38卷 / 04期
关键词：
POSTCHEMOTHERAPY SEMINOMA;
D O I：
10.4103/iju.iju_226_22
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In men with metastatic seminoma, negative fluorodeoxyglucose‑positron emission tomography/computed tomography (FDG-PET/CT) imaging indicates the absence of live seminoma cells[1] in the residual disease following chemotherapy. In this trial,[2] an interim FDG-PET/CT scan was used to determine whether men with favorable prognosis metastatic seminoma may be treated with two cycles of etoposide-cisplatin (EP) followed by only one cycle of carboplatin (CARBO), thus reducing the burden of treatment and toxicities. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.
引用
收藏
页码：325 / 326
页数：2
相关论文
共 50 条
  • [41] Value of Computed Tomography and Fluorodeoxyglucose-Positron Emission Tomography Imaging for Preoperative Screening in Advanced Heart Failure Therapies Candidates
    Rabbath, X.
    Pelletier-Galarneau, M.
    Tremblay-Gravel, M.
    Noly, P.
    Racine, N.
    Tan, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S358 - S358
  • [42] Evaluation of Healed Status in Tuberculosis of Spine by Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography and Contrast Magnetic Resonance Imaging
    Samarth Mittal
    Anil K. Jain
    K. L. Chakraborti
    Aditya Nath Aggarwal
    Lalendra Upreti
    Himanshu Bhayana
    Indian Journal of Orthopaedics, 2019, 53 : 160 - 168
  • [43] The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma
    Bantis, Athanasios
    Sountoulides, Petros
    Metaxa, Linda
    Pavlidis, Pavlos
    Aggelonidou, Eleni
    Arif, Halil
    Zisimopoulos, Athanasios
    UROLOGY ANNALS, 2016, 8 (04) : 496 - 499
  • [44] Comparison of Computed Tomography- and Positron Emission Tomography-Based Radiotherapy Planning in Cholangiocarcinoma
    Onal, Cem
    Topuk, Savas
    Yapar, Ali F.
    Yavuz, Melek
    Topkan, Erkan
    Yavuz, Aydin
    ONKOLOGIE, 2013, 36 (09): : 484 - 490
  • [45] Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging
    Antoch, G
    Jentzen, W
    Freudenberg, LS
    Stattaus, J
    Mueller, SP
    Debatin, JF
    Bockisch, A
    INVESTIGATIVE RADIOLOGY, 2003, 38 (12) : 784 - 789
  • [46] Clinical application of thallium 201 single-photon emission computed tomography and fluorodeoxyglucose-positron emission tomography in childhood brain tumors
    Smietana, S
    daSilva, E
    Kottamasu, S
    Aronin, P
    Bhambhani, K
    Chugani, H
    ANNALS OF NEUROLOGY, 1996, 40 (02) : 180 - 180
  • [47] Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma
    Sampath Santhosh
    Bhagwant Rai Mittal
    Deepak Kumar Bhasin
    Surinder Singh Rana
    Rajesh Gupta
    Ashim Das
    Ritambhra Nada
    Annals of Nuclear Medicine, 2017, 31 : 575 - 581
  • [48] Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma
    Santhosh, Sampath
    Mittal, Bhagwant Rai
    Bhasin, Deepak Kumar
    Rana, Surinder Singh
    Gupta, Rajesh
    Das, Ashim
    Nada, Ritambhra
    ANNALS OF NUCLEAR MEDICINE, 2017, 31 (08) : 575 - 581
  • [49] [18F] fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma
    Gururangan, S
    Hwang, E
    Herndon, JE
    Fuchs, H
    George, T
    Coleman, RE
    NEUROSURGERY, 2004, 55 (06) : 1280 - 1289
  • [50] Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography
    Cohen, MS
    Arslan, N
    Dehdashti, F
    Doherty, GM
    Lairmore, TC
    Brunt, LM
    Moley, JF
    SURGERY, 2001, 130 (06) : 941 - 946
12345